Music interventions in hyperacute and acute stroke patients

ISRCTN ISRCTN13104282
DOI https://doi.org/10.1186/ISRCTN13104282
Submission date
04/11/2024
Registration date
12/11/2024
Last edited
12/11/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Music and sounds have been shown to have beneficial effects on pain, anxiety and blood pressure in various settings. However, music and sound have not been studied specifically in patients with acute stroke. It is possible music or pleasant sounds may help control pain, anxiety or blood pressure abnormalities which may occur immediately following a stroke. This may supplement or negate the need for pharmacological medications which are commonly used but have known side effects.

Who can participate?
Patients aged 18 to 100 years old who are hospitalized within 24 hours from the onset of a suspected stroke

What does the study involve?
This study involves participants being randomly allocated, like a coin Filip, to listen to music or pleasant sounds for up to 12 hours following the onset of a stroke or to standard stroke care alone (without listening to music).

What are the possible benefits and risks?
There may be less pain or anxiety in those listening to music as compared to no music. Additionally, there may be less variability in blood pressure which is possibly harmful to stroke patients. Risks may include a patient not liking the use of music resulting in agitation or confusion.

Where is the study run from?
The University of Michigan Health-West, USA

When is the study starting and how long is it expected to run for?
January 2019 to September 2024

Who is funding the study?
The University of Michigan Health-West, USA

Who is the main contact?
Dr Jeffrey Fletcher, Jeffrey.fletcher@umhwest.org, jflet10121@aol.com

Contact information

Dr Jeffrey Fletcher
Public, Scientific, Principal Investigator

9636 Waterstone Dr SE
Byron Center, Michigan
49315
United States of America

Phone +1 7348458698
Email Jeffrey.fletcher@umhwest.org

Study information

Study designRandomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital, Medical and other records
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleDo music interventions, as compared to no music, reduce systolic blood pressure variability, pain and anxiety in hyperacute stroke
Study acronymMIHAS
Study objectivesPatients or their legally authorized representatives will be highly supportive of music interventions in hyperacute stroke. Music interventions will reduce pain, anxiety and systolic blood pressure variability in hyperacute stroke patients.
Ethics approval(s)

Approved 30/01/2020, University of Michigan Health-West Institutional Review Board (University of Michigan Health-West Professional Building, 2122 Health Dr. SW, Suite 233, Wyoming, MI 49519, United States of America; +1 616 252 5026; irb@umhwest.org), ref: 2020-010

Health condition(s) or problem(s) studiedTreatment of pain, anxiety and systolic blood pressure variability in patients hospitalized with acute stroke
InterventionEligible patients (or their legally authorized representative) were approached in the emergency department or obtained on admission to the inpatient ward and electronic consent. Staff not involved in the study implementation used a computer random number generator to generate a randomization sequence and allocation concealment was obtained by sealed opaque envelopes. Excluding the randomization process and use of the music or sound intervention (in the intervention group), all medical care of participants followed usual, disease-specific, care plans. Participants randomized to the intervention arm had 19 relaxation or pleasant sound stations to ambiently listen to on their in-room televisions. They also had options to listen to various music genres. Participants were asked to listen ambiently to music or sounds for the first hour of the trial and encouraged to listen to it frequently for the duration of the trial period however, there was not a specific time requirement. The trial period was a minimum of 6 hours with trial termination when the patient was discharged from the stroke unit, or neurological ICU, or after a maximum of 12 hours of data collection.
Intervention typeBehavioural
Primary outcome measure1. The percentage of eligible patients approached for consent who were recruited into the trial measured using data collected in study records at one timepoint
2. The percentage of enrolled patients who completed the 6-hour trial data collection measured using data collected in study records at one timepoint
Secondary outcome measures1. The systolic blood pressure variability (SBPV) in the first 6 hours of the trial period, defined by the standard deviation of the SBP in the treatment arms, measured using cuff blood pressure measurements hourly
2. Secondary exploratory outcomes included the effect of treatment arm assignment (intention to treat) on the visual analog pain scale (0-10) and anxiety (visual analog scale 0-100) burden at 6 hours from enrollment
Overall study start date03/01/2019
Completion date15/09/2024

Eligibility

Participant type(s)Patient
Age groupMixed
Lower age limit18 Years
Upper age limit100 Years
SexBoth
Target number of participants50
Total final enrolment30
Key inclusion criteriaPatients with acute stroke of any subtype admitted to the hospital within 24 hours of ictus
Key exclusion criteria1. Patients who refused consent
2. Patients at the end of life
3. Patients expected to have an operation or procedure
Date of first enrolment15/06/2024
Date of final enrolment15/09/2024

Locations

Countries of recruitment

  • United States of America

Study participating centre

University of Michigan Health-West
5900 Byron Center Ave
Wyoming
49519
United States of America

Sponsor information

Michigan Medicine
Hospital/treatment centre

University of Michigan Health-West, 5900 Byron Center Ave
Wyoming
49519
United States of America

Phone +1-616-252-5020
Email Research@umhwest.org
Website https://uofmhealthwest.org/
ROR logo "ROR" https://ror.org/01zcpa714

Funders

Funder type

Hospital/treatment centre

Michigan Medicine, University of Michigan
Government organisation / Universities (academic only)
Alternative name(s)
MEDICINE AT MICHIGAN, Michigan Medicine, MM
Location
United States of America

Results and Publications

Intention to publish date01/12/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a peer-reviewed journal
IPD sharing planThe dataset generated during the study will be available upon request from Dr Jeffrey Fletcher, Jeffrey.fletcher@umhwest.org, jflet10121@aol.com. Data will be stored for 7 years from publication date. The type of data that will be shared is anonymized individualized-level patient data.

Editorial Notes

05/11/2024: Study's existence of the University of Michigan Health-West, Michigan Medicine, Institutional Review Board.